Clinical Trial Update: Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tadalafil for dyspnea in patients with COPD-related pulmonary hypertension is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Hypertension

Drugs mentioned

• TADALAFIL (TADALAFIL)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Chronic Obstructive Pulmonary Disease, Pulmonary Hypertension | Phase 2 | Status: RECRUITING